Notably, Cx36 contributes to neuronal death following a range of acute brain insults such as ischemia, traumatic brain injury, and epilepsy, suggesting that specific blockers of Cx36 GJC might be useful for treating these pathological situations17. Here, GJD2 is linked to epilepsy.